Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cataract surgery
MedTech
Alcon, Lensar drop $356M deal after black eye from FTC
The FTC threatened to challenge the deal that would have seen Alcon acquire Lensar’s robotic laser systems for cataract surgery.
Conor Hale
Mar 17, 2026 11:00am
ForSight Robotics raises $125M to trial eye surgery platform
Jun 24, 2025 11:40am
Bausch + Lomb identifies cause of intraocular lens recall
May 6, 2025 11:30am
Hibernating squirrels hold protein that clears cataracts: study
Sep 20, 2024 11:58am
Formosa sells Brazilian rights to near-approval eye drug
Jan 26, 2024 9:20am
Alcon reaches $199M settlement with J&J Vision
Feb 13, 2023 2:15pm
